申请人:Cooper Laboratories, Inc.
公开号:US04139537A1
公开(公告)日:1979-02-13
Cardiac arrhythmias can be treated by administering an effective amount of 3-aryloxy-1-(2-or 4-iminodihydro-1-pyridyl)-2-propanol or phamaceutically acceptable acid addition compound. Many new effective compounds of this type are disclosed.
心脏节律异常可以通过施用有效量的3-芳氧基-1-(2-或4-亚氨基二氢-1-吡啶基)-2-丙醇或药学上可接受的酸加成盐来治疗。许多此类新型有效化合物已被公开。